GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alpa Laboratories Ltd (BOM:532878) » Definitions » Piotroski F-Score

Alpa Laboratories (BOM:532878) Piotroski F-Score : 6 (As of May. 18, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Alpa Laboratories Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Alpa Laboratories has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Alpa Laboratories's Piotroski F-Score or its related term are showing as below:

BOM:532878' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 5   Max: 9
Current: 6

During the past 13 years, the highest Piotroski F-Score of Alpa Laboratories was 9. The lowest was 3. And the median was 5.


Alpa Laboratories Piotroski F-Score Historical Data

The historical data trend for Alpa Laboratories's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpa Laboratories Piotroski F-Score Chart

Alpa Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 9.00 5.00 5.00 6.00

Alpa Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 6.00 - - -

Competitive Comparison of Alpa Laboratories's Piotroski F-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Alpa Laboratories's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpa Laboratories's Piotroski F-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alpa Laboratories's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Alpa Laboratories's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar23) TTM:Last Year (Mar22) TTM:
Net Income was ₹126 Mil.
Cash Flow from Operations was ₹89 Mil.
Revenue was ₹924 Mil.
Gross Profit was ₹309 Mil.
Average Total Assets from the begining of this year (Mar22)
to the end of this year (Mar23) was (1552.39 + 1672.699) / 2 = ₹1612.5445 Mil.
Total Assets at the begining of this year (Mar22) was ₹1,552 Mil.
Long-Term Debt & Capital Lease Obligation was ₹8 Mil.
Total Current Assets was ₹1,491 Mil.
Total Current Liabilities was ₹319 Mil.
Net Income was ₹141 Mil.

Revenue was ₹1,105 Mil.
Gross Profit was ₹344 Mil.
Average Total Assets from the begining of last year (Mar21)
to the end of last year (Mar22) was (1403.684 + 1552.39) / 2 = ₹1478.037 Mil.
Total Assets at the begining of last year (Mar21) was ₹1,404 Mil.
Long-Term Debt & Capital Lease Obligation was ₹21 Mil.
Total Current Assets was ₹1,380 Mil.
Total Current Liabilities was ₹314 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Alpa Laboratories's current Net Income (TTM) was 126. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Alpa Laboratories's current Cash Flow from Operations (TTM) was 89. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar22)
=125.828/1552.39
=0.08105437

ROA (Last Year)=Net Income/Total Assets (Mar21)
=140.917/1403.684
=0.10039083

Alpa Laboratories's return on assets of this year was 0.08105437. Alpa Laboratories's return on assets of last year was 0.10039083. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Alpa Laboratories's current Net Income (TTM) was 126. Alpa Laboratories's current Cash Flow from Operations (TTM) was 89. ==> 89 <= 126 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=7.771/1612.5445
=0.00481909

Gearing (Last Year: Mar22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar21 to Mar22
=21.246/1478.037
=0.01437447

Alpa Laboratories's gearing of this year was 0.00481909. Alpa Laboratories's gearing of last year was 0.01437447. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar23)=Total Current Assets/Total Current Liabilities
=1491.238/319.152
=4.67250088

Current Ratio (Last Year: Mar22)=Total Current Assets/Total Current Liabilities
=1380.11/313.834
=4.39757961

Alpa Laboratories's current ratio of this year was 4.67250088. Alpa Laboratories's current ratio of last year was 4.39757961. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Alpa Laboratories's number of shares in issue this year was 21.041. Alpa Laboratories's number of shares in issue last year was 21.041. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=309.132/924.102
=0.33452151

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=344.261/1105.133
=0.31151092

Alpa Laboratories's gross margin of this year was 0.33452151. Alpa Laboratories's gross margin of last year was 0.31151092. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar22)
=924.102/1552.39
=0.59527696

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar21)
=1105.133/1403.684
=0.78730897

Alpa Laboratories's asset turnover of this year was 0.59527696. Alpa Laboratories's asset turnover of last year was 0.78730897. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+0+1+1+1+1+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Alpa Laboratories has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Alpa Laboratories  (BOM:532878) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Alpa Laboratories Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Alpa Laboratories's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Alpa Laboratories (BOM:532878) Business Description

Traded in Other Exchanges
Address
33/2, A.B. Road, Pigdamber, Rau, Indore, MP, IND, 453446
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the business segment of Drugs and Chemicals. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.

Alpa Laboratories (BOM:532878) Headlines

No Headlines